Diabetology & metabolic syndrome. 2022 Aug 26;14(1):122. doi: 10.1186/s13098-022-00895-w Q23.92025
The association between advanced glycation end products (AGEs) and ABC (hemoglobin A1C, blood pressure, and low-density lipoprotein cholesterol) control parameters among patients with type 2 diabetes mellitus
糖尿病患者血液中晚期糖基化产物与ABC指标之间的关系:横断面研究 翻译改进
作者单位 +展开
作者单位
DOI: 10.1186/s13098-022-00895-w PMID: 36028845
摘要 Ai翻译
相关内容
-
Higher hemoglobin A1C and atherogenic lipoprotein profiles in children and adolescents with type 2 diabetes mellitus
2型糖尿病儿童及青少年较高的糖化血红蛋白A1C和致动脉粥样硬化脂蛋白档案
James Heath Pelham et al.
Journal of clinical & translational endocrinology. 2018 Nov 30:15:30-34.
-
Limitations of hemoglobin A1c in the management of type 2 diabetes mellitus
糖化血红蛋白在二型糖尿病治疗中的局限性
Nemin Adam Zhu
Canadian family physician Medecin de famille canadien. 2020 Feb;66(2):112-114.
-
The role of hemoglobin A1c as a predictor of major adverse cardiovascular events in patients with type 2 diabetes mellitus after percutaneous coronary intervention: a case-cohort study
糖化血红蛋白预测经皮冠状动脉介入治疗后2型糖尿病患者主要心血管不良事件的队列研究
Babak Bagheri et al.
BMC cardiovascular disorders. 2024 Oct 22;24(1):583.
-
Diagnostic value of hemoglobin A1c for type 2 diabetes mellitus in a population at risk
糖化血红蛋白在筛查2型糖尿病中的诊断价值分析
A Peter et al.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association. 2011 Apr;119(4):234-7.
-
Challenges to hemoglobin A1c as a therapeutic target for type 2 diabetes mellitus
糖化血红蛋白A1c作为2型糖尿病治疗靶点的挑战
Masayuki Ikeda
Journal of general and family medicine. 2019 Apr 4;20(4):129-138.
-
Effect of Hemoglobin A1c Reduction or Weight Reduction on Blood Pressure in Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Treatment in Type 2 Diabetes Mellitus: A Meta-Analysis
二甲双胍联合GLP-1受体激动剂和SGLT-2抑制剂降糖减重对2型糖尿病患者血压影响的meta分析
Mengdie Hu et al.
Journal of the American Heart Association. 2020 Apr 7;9(7):e015323.
-
Baseline low-density lipoprotein cholesterol predicts the hemoglobin A1c-lowering effect of dapagliflozin in Japanese patients with type 2 diabetes mellitus
基线低密度脂蛋白胆固醇可预测达格列净在日本2型糖尿病患者中的糖化血红蛋白降低效应
Tomoyuki Iwasaki
Diabetology international. 2015 May 31;7(1):77-82.
-
Hemoglobin A1c Targets for Nonpregnant Adults With Type 2 Diabetes Mellitus
非妊娠成人2型糖尿病患者糖化血红蛋白(A1C)控制目标
Annals of internal medicine. 2018 Apr 17;168(8).

期刊名:Diabetology & metabolic syndrome
缩写:DIABETOL METAB SYNDR
ISSN:N/A
e-ISSN:1758-5996
IF/分区:3.9/Q2